Genocea Biosciences (GNCA) Misses Q4 EPS by 11c

Genocea Biosciences (NASDAQ: GNCA) reported Q4 EPS of ($0.66), $0.11 worse than the analyst estimate of ($0.55).

For earnings history and earnings-related data on Genocea Biosciences (GNCA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c